Early Life Rhinovirus Infection and Childhood Asthma
Early Life Rhinovirus Infection and Childhood Asthma
批准号:
10443694
负责人:
Marc B. Hershenson
金额:
$45.36万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-07-03 至 2025-06-30
关键词:
13 year oldAllergensAllergicAsthmaAttenuatedBiological AssayBirthBrush CellCASP1 geneCanis familiarisCell physiologyCellsChemicalsChildChildhood AsthmaCohort StudiesCurettage procedureDataDevelopmentEpithelial CellsEquilibriumFlow CytometryGenomeHela CellsHouse DustHumanImmuneImmunofluorescence ImmunologicInbred BALB C MiceInfantInfectionInflammasomeInflammationInterferon Type IIInterleukin-1 betaInterleukin-13Knockout MiceLeukotriene E4LifeLower respiratory tract structureLungLymphoid CellMeasuresMetaplasiaMucous body substanceMusNetherlandsNeutralization TestsNeutralizing antibody assayNosePathogenesisPhenotypePreventionProductionRegulationRespiratory Tract InfectionsRespiratory syncytial virusRhinovirusRhinovirus infectionRiskRisk FactorsRoleShorthandSignal TransductionTSLP geneTestingTissuesViralViral Respiratory Tract InfectionVirus DiseasesWestern AustraliaWestern BlottingWheezingWisconsinWorkZileutonairway epitheliumairway hyperresponsivenessairway inflammationasthma preventioncohortcytokineeosinophilic inflammationinhibitorinsightmacrophagemouse modelneutralizing antibodynew therapeutic targetresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Birth cohort studies have found significant associations between early-life wheezing-associated respiratory
tract infections and the development of asthma in children up to 13 years of age. These studies suggest that
early life respiratory tract infections have a direct effect on lung and/or immune cell development and the risk of
asthma. To determine possible mechanisms, we established a mouse model of early-life RV infection. Infection
of 6 day-old mice, but not mature mice, induces long-lasting mucous metaplasia, eosinophilic inflammation and
airways hyperresponsiveness (AHR) which is associated with type 2 innate lymphoid cell (ILC2) expansion and
dependent on IL-13, IL-25 and IL-33. For this renewal application, we have developed preliminary data
showing that early-life RV infection increases the number of airway IL-25+ DCLK1+ brush cells, providing a
mechanism for a persistent ILC2-dependent asthma-like phenotype. In addition, we have found that, in
immature mice, activation of the NLRP3 inflammasome and IL-1β maturation inhibits type 2 cytokine
expression and mucous metaplasia. In this proposal, we will test the general hypothesis that, following early-
life RV infection, development of ILC2-dependent type 2 airway inflammation and mucous metaplasia
represents a balance between tuft cell RV-induced IL-25 signaling (promotes the phenotype) and NLRP3-
dependent IL-1β signaling (suppresses the phenotype). To test this, we propose the following Aims:
Specific Aim 1. Determine the contribution of airway brush (tuft) cells to viral-induced IL-25
production. We hypothesize that: 1) early-life RV infection stimulates a persistent increase in the number of
IL-25-producing airway tuft cells; 2) tuft cells are required for RV-induced ILC2 expansion, mucous metaplasia
and AHR; 3) RV-induced IL-25 and IL-13 production (by ILC2s and M2 polarized macrophages) constitute a
feed-forward mechanism for tuft cell development.
Specific Aim 2. Determine the role of IL-1β on the development of RV-induced mucous metaplasia
and AHR. We hypothesize that: 1) in immature mice, RV-induced, NLRP3 inflammasome-dependent IL-1β
production suppresses the asthma-like phenotype; 2) IL-1β inhibits epithelial cell innate cytokine expression;
and 3) LPS and dog-associated house dust each attenuate development of the mucous metaplasia phenotype
by stimulating inflammasome priming and activation.
Specific Aim 3. Determine the effects of early-life RV-C infection. We hypothesize that: 1) compared
to RV-A, RV-C infection of 6 day-old mice induces more type 2 inflammation, mucous metaplasia and AHR; 2)
RV-C induces greater expansion of tuft cells; 3) RV-C elicits inflammasome priming but not activation, thereby
permitting greater and more long-lasting type 2 cytokine expression and mucous metaplasia.
Immature mice and infants with respiratory viral infections will be studied. Completion of the proposed work
will provide new insight into the pathogenesis of asthma development, and identify new targets for prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10093541
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10459511
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10682418
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Models of rhinovirus-C respiratory infection and asthma
-
批准号:10268220
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Respiratory Enteroviruses, Inflammasome Activation and Innate Immune Cells
-
批准号:10299951
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2020
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:9128143
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2016
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:9233004
-
项目类别:
-
资助金额:$44.67万
-
财政年份:2016
-
负责人:Marc B. Hershenson
-
依托单位:
S-Nitrosothiol-Based Rinse/Aerosol Solutions For Treatment/Prevention of Rhinosinusitis
-
批准号:8980847
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:10651800
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Early Life Rhinovirus Infection and Childhood Asthma
-
批准号:10200651
-
项目类别:
-
资助金额:$45.36万
-
财政年份:2015
-
负责人:Marc B. Hershenson
-
依托单位:
Rhinovirus and Airway Epithelial Cell Responses
-
批准号:7822366
-
项目类别:
-
资助金额:$2.4万
-
财政年份:2009
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7642308
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7497962
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7666430
-
项目类别:
-
资助金额:$1.85万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7877980
-
项目类别:
-
资助金额:$40.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7334302
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Multipotent lung mesenchymal cells in neonatal lung injury
-
批准号:7881828
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:Marc B. Hershenson
-
依托单位:
Mechanisms of Airway Smooth Muscle Hypertrophy
-
批准号:7266235
-
项目类别:
-
资助金额:$36.7万
-
财政年份:2006
-
负责人:Marc B. Hershenson
-
依托单位:
Rhinovirus and Airway Epithelial Cell Responses
-
批准号:8039582
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2006
-
负责人:Marc B. Hershenson
-
依托单位:
Mechanisms of Airway Smooth Muscle Hypertrophy
-
批准号:8693000
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2006
-
负责人:Marc B. Hershenson
-
依托单位:
海外基金